comparemela.com
Home
Live Updates
Sen-Jam Pharmaceutical Announces Upcoming Completion of SJP-002C Clinical Trial, Offering Hope for a Safe, Potent, and Globally Affordable Treatment for Upper Respiratory Infections and COVID-19 : comparemela.com
Sen-Jam Pharmaceutical Announces Upcoming Completion of SJP-002C Clinical Trial, Offering Hope for a Safe, Potent, and Globally Affordable Treatment for Upper Respiratory Infections and COVID-19
/PRNewswire/ -- Sen-Jam Pharmaceutical, a leading innovator in the development of therapeutics for age-related diseases, is pleased to announce the upcoming...
Related Keywords
Alexander Limkakeng
,
Prnewswire Sen
,
Christine Leonard
,
Jim Iversen
,
National University Of Singapore
,
Duke University
,
National Research Foundation Award
,
Jam Pharmaceutical
,
Upper Respiratory Infections
,
Sen Jam Pharmaceutical
,
Good Manufacturing Practice
,
Duke National University
,
Research Foundation Award
,
comparemela.com © 2020. All Rights Reserved.